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Abstract
The mechanism by which heart rate (HR) control with esmolol improves
hemodynamics during septic shock remains unclear. Improved right ventricu-
lar (RV) function, thereby reducing venous congestion, may play a role. We
assessed the effect of HR control with esmolol during sepsis on RV function,
macrocirculation, microcirculation, end-organ-perfusion, and ventricular-
arterial coupling. Sepsis was induced in 10 healthy anesthetized and mechani-
cally ventilated sheep by continuous IV administration of lipopolysaccharide
(LPS). Esmolol was infused after successful resuscitation of the septic shock,
to reduce HR and stopped 30-min after reaching targeted HR reduction of
30%. Venous and arterial blood gases were sampled and the small intestines’
microcirculation was assessed by using a hand-held video microscope (Cyto-
Cam-IDF). Arterial and venous pressures, and cardiac output (CO) were
recorded continuously. An intraventricular micromanometer was used to
assess the RV function. Ventricular–arterial coupling ratio (VACR) was esti-
mated by catheterization-derived single beat estimation. The targeted HR
reduction of >30% by esmolol infusion, after controlled resuscitation of the
LPS induced septic shock, led to a deteriorated RV-function and macrocircu-
lation, while the microcirculation remained depressed. Esmolol improved
VACR by decreasing the RV end-systolic pressure. Stopping esmolol showed
the reversibility of these effects on the RV and the macrocirculation. In this
animal model of acute severe endotoxic septic shock, early administration of
esmolol decreased RV-function resulting in venous congestion and an unim-
proved poor microcirculation despite improved cardiac mechanical efficiency.
Introduction
Sepsis is one of the leading causes of death among hospi-
talized patients and a frequent cause of admission to
intensive care units (ICUs)(Mayr et al. 2014). Morbidity
and mortality from sepsis in ICU patients remain high,
despite an improved understanding of the pathophysiol-
ogy of sepsis (Angus et al. 2001; Martin et al. 2003).
Therefore, the search for effective therapeutic strategies
remains relevant (Ince 2015).
Heart rate (HR) control by esmolol, a an ultrashort acting
b1-adrenoceptor antagonist could be such a novel therapeutic
strategy with substantial impact on the clinical management
of septic shock. Reduced HR could improve the cardiac mis-
match of oxygen demand and supply in septic patients, by
decreasing myocardial oxygen consumption (Hosokawa et al.
2017). The study by Morelli et al. shows that esmolol is able
to control noncompensatory tachycardia during established
septic shock after 24 h of hemodynamic optimization and
reduce mortality from 81% to 49%. Together with a reduc-
tion in HR, they showed that esmolol was able to improve
macrocirculatory variables significantly, while the microvas-
cular blood flow was preserved and the frequency of adverse
events did not increase (Morelli et al. 2013a).
Although these results look promising, the optimal
dosage, initiation and the mechanism by which esmolol
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might improve hemodynamic and organ function and
reduce mortality remain to be elucidated (Pinsky 2013;
Orbegozo Cortes et al. 2014). It is hypothesized that HR
reduction during septic shock may improve right ven-
tricular (RV) diastolic function, leading to increased car-
diac preload by reducing venous congestion and thereby
increasing effective organ perfusion (Harkin et al. 2000;
Park et al. 2008; Legrand et al. 2013; Morelli et al.
2013b; Ince 2015). These possible positive effects of
esmolol on RV function have only been described using
echocardiography (Morelli et al. 2014). However, to
obtain more mechanistic insights, a comprehensive
approach using intraventricular measurements should be
performed. Another supposed beneficial effect of esmolol
in septic patients may be related, at least in part, to
reduced afterload by better ventricular–arterial (V–A)
coupling. V-A coupling is a key determinant of cardio-
vascular function by describing the interaction between
the ventricle (contractility) and the arterial system (after-
load)(Razzolini et al. 2004; Dekleva et al. 2015; Morelli
et al. 2016). Decoupling of contractility and afterload is
clearly present in patients with septic shock and may
persist after resuscitation to recommended hemodynamic
targets (Guarracino et al. 2013, 2014).
In this study, we aimed to elucidate the effect of early
initiation of HR control by esmolol on RV function in
the acute stage of resuscitated sepsis (<24 h). Using a
lamb model of resuscitated severe septic shock, we inves-
tigated both the RV function and V-A coupling, the
macrocirculation, microcirculation and end-organ-perfu-
sion as a result of esmolol infusion.
Materials and Methods
This experiment was performed after approval of the
local ethics committee on animal research of the Rad-
boud University Medical Center (RUMC License number
RU-DEC 2014–10) and in full compliance with Dutch
and European legal requirements on the use and protec-
tion of laboratory animals. Ten conventionally reared
female lambs (crossbred Texelaar-Flevolanders) under
general anesthesia were studied. No control group was
considered necessary since the animals acted as their
own control.
Anesthesia and ventilation
Premedication consisted of midazolam (0.5 mg/kg) and
ketamine (4 mg/kg), anesthesia was performed using IV
administration of propofol (2 mg/kg). After endotracheal
intubation, general anesthesia was maintained using
inhalation of isoflurane (0.5–2 volume%), the continu-
ous IV administration of sufentanil (2 lg/kg per h) and
rocuronium (1 mg/kg per h) after a loading dose of
1 mg/kg. The lungs were mechanically ventilated using a
volume-controlled mode with tidal volumes of 8–10 mL/
kg, 5 cmH2O PEEP, FiO2 0.4, and an inspiratory-to-
expiratory ratio of 1:2. Ventilation was adjusted accord-
ing to the end tidal CO2 level. Impaired oxygenation
was treated by increasing PEEP and or increasing the
FiO2 to maintain an oxygen saturation > 95%. During
the experiment, continuous IV dextrose 10% 2.4 mL/kg
per h (240 lg/kg per min dextrose) was administered
supplemented with IV 0.9% saline 2–4 mL/kg per h in
order to maintain fluid balance and to prevent hypo-
glycemia. At the end of the experiment, the animals
were euthanized with an overdose of pentobarbital
(150 mg/kg IV) (T3).
Surgical preparation
All lambs were positioned in dorsal position for inserting
the intravascular catheters using surgical cut down proce-
dures. A 7.5F x 20 cm triple-lumen central venous cathe-
ter was placed in the left internal jugular vein (Multicath,
Vygon Nederland BV) for central venous blood pressure
monitoring, venous blood sampling, and for the adminis-
tration of fluid and drugs. A 18G 9 10 cm single-lumen
catheter (Leaderflex, Vygon Nederland BV) was intro-
duced in the right femoral artery for arterial blood pres-
sure monitoring and blood sampling.
A 5F 9 8 cm introducer sheath (Cordis Europe,
Waterloo, Belgium) was introduced followed by a 5F
guiding catheter (ImpulseTM, Boston scientific, Kerkrade,
The Netherlands) into the right internal jugular vein.
The guiding catheter was advanced using fluoroscopy
until RV blood pressure was recorded at the tip. The
ComboWire XT (Volcano Corporation, Rancho Cor-
dova, CA), a 0.014-in dual-sensor (pressure and Doppler
velocity)-equipped guide wire, was advanced into the
guiding catheter. The guiding catheter was pulled back
in order to locate its tip in the right atrium and leave
the pressure wire in the RV. The ComboWire XT pres-
sure wire was used to perform RV pressure measure-
ments continuously.
Next, the lambs were repositioned for the duration of
the experiment in the right lateral position. An ultra-
sound transit-time perivascular flow probe (14 or
16 mm) (PAX series, Transonic Systems, Ithaca, NY) was
placed around the main pulmonary artery to measure CO
after left thoracotomy. Laparotomy created a window for
Incident Dark Field (IDF) imaging the of the small
intestines’ microcirculation. Gastrostomy was performed
in order to place a 30 cm tube for gastric decompression.
Last, an 8F silicon Foley catheter (Covidien, Mansfield,
MA 02048, USA) was introduced into the bladder.
2018 | Vol. 6 | Iss. 18 | e13882
Page 2
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
Influence of Esmolol on Right Ventricle in Sepsis L. M. van Loon et al.
Resuscitated endotoxic shock
After closing all the incisions, the chest and the abdomen,
and prior to creating a situation of resuscitated endotoxic
shock, we gave a fluid bolus (5–10 mL/kg) to treat poten-
tial initial hypovolemia related to induction of anesthesia
and surgical manipulation. Next, a stabilization period of
30 min (T0) was followed by continuous IV administra-
tion of lipopolysaccharide (3 lg/kg per h) (LPS, US Stan-
dard Reference Endotoxin Escherichia coli O:113) after a
loading dose of 3 lg/kg, see Figure 1. The LPS dose was
defined from previous pilot experiments. Resuscitation
started 30 min after LPS induced a 50% reduction in CO
or a 25% reduction in ABP (T1). Resuscitation objectives
were to return ABP and CO to their baseline values. A
fluid load of 50 mL of saline (or whole blood if hemoglo-
bin level<5 mmol/L) was administered initially to evaluate
fluid responsiveness guided by flow probe CO; in case of
absence of fluid response, nor-epinephrine and/or dobu-
tamine were used. The initial dose of nor-epinephrine
and dobutamine was 0.1 lg/min per kg and 0.5 lg/min
per kg, respectively, and could be increased to up to
1.5 lg/min per kg and 2.5 lg/min per kg, respectively to
achieve resuscitation goals. In all animals this protocol
leads to restoration of blood pressure and CO.
Experimental protocol
Thirty minutes after creating a situation of resuscitated
endotoxic shock (T1), esmolol (Baxter,Maurepas, France)
was started at 50 lg/kg per min and progressively
increased to reduce in the HR by 30%. A percentage
change – in the same magnitude as Morelli et al. (2013a)-
was used to allow for differences in resting HR. Resuscita-
tion maneuvers were maintained or increased in order to
maintain ABP and CO at baseline values; except for
dobutamine dosage, which was kept constant in order not
to intervene with the esmolol treatment. Esmolol infusion
was stopped 30 min after the HR reached the targeted
reduction of 30% (T2), see Figure 1.
Data collection
Electrocardiography (EKG), blood pressures, and pulmonary
flow were simultaneously and continuously recorded on a
laptop computer and stored on a hard disk with a sample
rate of 200 Hz by an A/D converter (NI USB-6211, National
Instrument, Austin, TX, USA). Before, during, and after the
esmolol infusion, five sequences of 10s clips of the small
intestines’ microcirculation were obtained with the Cyto-
cam-IDF video microscope (Braedius Medical, Huizen, the
Netherlands). Image acquisition was performed according to
published consensus criteria (De Backer et al. 2007). A
hand-held iSTAT point-of-care analyzer (Abbott Labora-
tories, IL, USA) was used to obtain arterial hematocrit,
hemoglobin, partial pressure of CO2 and Urea.
Data analysis
A blinded investigator (LvL) scored the captured IDF
clips according to Massey et al. In short, images were
scored on six categories: illumination, duration, focus,
content, stability, and pressure. Videos are assigned a
score of 0 = good, 1 = acceptable, or 10 = unacceptable
for each category. Any video with composed scored ≥10
was discarded from future analysis. Automated Vascular
Analysis (AVA 5; Microvision Medical B.V.) was used for
off-line analysis on the images of the sublingual region
that met the quality requirements. The continuously
recorded EKG, pressure and flow signals were analyzed
using custom-written MATLAB scripts (Matlab R2017b,
The MathWorks Inc. Massachusetts, USA). Mean ABP,
CVP and CO were acquired by taking a fourth order But-
terworth low-pass filter with a cuff-off frequency of
0.02 Hz from their raw signal. HR was acquired by auto-
matic detection of R-peaks from the EKG-signal.
RV contractile function (dP/dt_max/P) was acquired
by taking the peak-first-derivative of RV pressure wave-
form divided by the pressure at that point. The maximum
isovolumetric pressure (Pmax) provides an estimate of the
maximum pressure that could be generated during an iso-
volumetric contraction and was determined by fitting a
sinusoid to the isovolumetric regions of the pressure trac-
ing, the so-called “single beat method” (Sunagawa et al.
1980; Takeuchi et al. 1991; Lambermont et al. 2004). Tau
was calculated by the method of Weiss et. al, assuming a
zero asymptote (Weiss et al. 1976). Ventricular-arterial
coupling ratio (VACR) of the RV was approximated by
dividing end-systolic pressure (Pes) by the difference
between Pmax and Pes (Truong et al. 2015).
LPS infusion
Esmolol infusion
Resuscitation
T0 T1 T2 T3Start 
experiment
End 
experiment60–120 min 30–60 min 30–90 min 30–90 min 30 min
Figure 1. Schematic overview of the experimental design.
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Statistical analysis
Prism Statistical Software was used for statistical analysis
(Graph-Pad Prism 5, GraphPad Software Inc., San Diego,
CA, USA). RV systolic and diastolic parameters were nor-
malized to baseline. One-way analysis of variance
(ANOVA) and the Bonferroni test was used for multiple
post-hoc comparisons of the different time points. A P-
value of < 0.05 was considered to indicate significance
(*=P < 0.05, **=P < 0.01, and ***=P < 0.001).
Results
A total of 10 female lambs were studied. They were 6-
8-month-old, weighing a mean of 20.6 kg [range: 13–
24.5 kg] and with a mean body surface area of
0.91 m2 [range: 0.67–1.0 m2]. All animals included in
the study were considered healthy on physical exami-
nation when entering the animals’ laboratory. In all
animals, LPS infusion plus resuscitation maneuvers
caused a septic shock with increased CO, tachycardia,
and significantly decreased microcirculatory parameters.
Lactate increased significantly over the course of the
experiment and was produced aerobic (Pv-aCO2/Ca-
vO2 < 1.4 and ScvO2 > 70%) (Table 1). Hematocrit
and hemoglobin remained within physiological (base-
line) ranges.
Effect of esmolol
Esmolol infusion induced on average a HR reduction
of 37% [range: 31–41%]. This was accompanied with
a significant impairment in MAP, CI, and both RV
function parameters (systolic and diastolic), see Fig-
ure 2 and Table 1. This impairment led to venous
congestion, indicated by a significantly increased CVP.
The microcirculation of the small intestines remained
depressed ultimately, see Figure 3. Apart from the
microcirculation, these effects were reversible by stop-
ping esmolol infusion, showing that the deteriorated
hemodynamics was not due to progressive endotoxic
effects of LPS.
The measurements of Pes, Pmax, and VACR by sin-
gle beat estimation are shown in Figure 4B. During
esmolol infusion, a trend toward a decreased RV end-
systolic pressure and increased estimated RV maximum
pressure was seen. This trend resulted in a significant
difference between both, showing that esmolol forced
the RV to operate below its maximum capacity. This
was accompanied by a significant decrease in the
VACR (from 7.6 to 3.5 on average), indicating
increased cardiac mechanical efficiency during the
infusion of esmolol.
Effect of esmolol on resuscitation
requirements
Vasopressor requirements increased during esmolol infu-
sion, while only an additional 2 mL/kg saline [range: 0–
5.6 mL/kg] was given in boluses guided by the continu-
ous CO monitoring. This limited amount of fluid showed
the reduced fluid responsiveness of the animals during
esmolol infusion. Maximum nor-epinephrine dosage
increased from 1.4 lg/min per kg at T1 to 1.8 lg/min
per kg at T2 [range: 1–2.7 lg/min per kg], and returned
to 1.5 lg/min per kg at T3. Dobutamine administration
remained unchanged, as stated in the protocol. Two ani-
mals became severely bradycardic during esmolol infusion
necessitating two boluses of epinephrine and CPR. There-
fore, we excluded their data from phase after stopping
esmolol.
Discussion
In this experimental model of acute septic shock, beta-
blockade with esmolol decreased HR with 37% and
induced a significant worsening in macrohemodynamic
parameters without recovery of the microcirculation. We
showed that the negative effects of esmolol on the macro-
circulation could be attributed to a decreased RV func-
tion.
We created a model of resuscitated septic shock to test
the efficacy of beta-blockade using esmolol. The severity
of initial shock was characterized by increased lactate
levels in combination with a significant reduction in CO,
MAP, and SV in all animals. Resuscitation with fluids
and vasoactive drugs had a positive effect on all macrohe-
modynamic parameters and changed a hypodynamic
hypotensive “cold” shock, induced by LPS, into a “warm”
(or hyperdynamic) septic shock. In doing so, we feel that
this model was robust enough to resemble clinical signifi-
cant severe septic shock in humans.
In contrast to other animal and human studies (Suzuki
et al. 2005; Mori et al. 2011; Morelli et al. 2014; Hernan-
dez et al. 2016), our results revealed that esmolol had a
negative effect on the macrocirculation and failed to
improve the affected microcirculation. These negative
effects could be explained by a decrease in RV function.
First, the observed reduction in RV diastolic function
(tau) would have caused a negative effect on preload.
This RV dysfunction was confirmed by a markedly ele-
vated CVP, which is associated with reduced microvascu-
lar perfusion, increased organ dysfunction and mortality
(Damman et al. 2009). Increased tau, after esmolol infu-
sion in a nonseptic setting, has been described in other
studies in both the right (Sun et al. 2006) and left ventri-
cle (Firstenberg et al. 2001). This is caused by the
2018 | Vol. 6 | Iss. 18 | e13882
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negative lusitropic effects of esmolol and is reported to be
even more pronounced in the RV compared to the LV
(Cortina et al. 2007). Second, the reduced RV dP/dt/
P_max reflects an intrinsic myocardial effect and is
indicative of an impaired systolic function (Kanzaki et al.
2002; Leeuwenburgh et al. 2002). Esmolol is known for
shifting the systolic portion of the pressure–volume
downward (Dickstein et al. 1995).
The CVP decreased and the reduced RV systolic and
diastolic function recovered after stopping the esmolol
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Figure 2. Macrocirculatory variables per study phase. Data are expressed as mean  SD. Bonferroni’s post-hoc test was used to perform
pairwise comparisons between phases. *=P < 0.05, and, ***=P < 0.001. (A) Mean arterial pressure (MAP) and central venous pressure (CVP).
(B) Cardiac output (CO), Heart rate (HR) and stroke volume (SV).
Table 1. Effect of esmolol on hemodynamic and metabolic parameters. Data are expressed as mean  SD.
Variable
Baseline
(T0)(n = 10)
Resuscitated
endotoxic shock (T1)
(n = 10)
Esmolol (T2)
(n = 10)
Stop (T3)
(n = 8)
Sign
(T0–T1)
Sign
(T1–T2)
Sign
(T2–T3) P1
Systolic arterial pressure
(mmHg)
76  11 74  11 46  12 67  11 NS *** ** P < 0.001
Diastolic arterial pressure
(mmHg)
49  8 48  8 32  8 43  9 NS *** NS P < 0.001
RV dP/dt_min (mmHg/sec) 1.3  0.7 1.8  0.5 1.4  0.4 1.6  0.5 NS NS NS NS
Cardiac index (L/min per m2) 3.5  1.1 4.5  1.5 2.4  0.8 3.3  0.6 NS ** NS P < 0.01
Lactate (g/mol) 1.9  1.3 3.5  0.9 4.3  1.2 4.3  1.2 * NS NS P < 0.001
Hemoglobin (g/dL) 4.6  0.6 5.5  0.7 5.3  0.8 5.4  0.7 * NS NS P < 0.05
Hematocrit (L/L) 0.22  0 0.26  0 0.25  0 0.25  0 * NS NS P < 0.05
Urea (mmol/L) 7.1  1.3 7.5  1.5 8.2  2.3 7.5  1.2 NS NS NS NS
PaCO2 (mmHg) 43  5.8 49  12.6 45  4.8 47  2.3 NS NS NS NS
PvCO2 (mmHg) 46  3.9 53  13.4 51  5.2 51  1.5 NS NS NS NS
ScvO2 (%) 86  4 90  4 87  5 89  4 NS NS NS NS
pH 7.4  0.06 7.3  0.09 7.3  0.5 7.3  0.08 * NS NS P < 0.05
Base excess (mmol/L) 3.4  3.7 0.4  3.9 0  4.4 0  6.6 NS NS NS NS
HCO3 (mmol/L) 27.8  3.1 24.7  2.2 24.5  2.0 24.3  2.0 NS NS NS P < 0.05
1NS, Not significant.
1Significant changes over time (comparison made using one-way ANOVA), *= P < 0.05, **= P < 0.01 and ***= P < 0.001.
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infusion. This indicates that esmolol forced the RV to
underperform, despites severe hypotension, resulting in
low CO. The reversible underperformance was supported
by measurements using the single beat method. The Pmax
was unaffected, but the gap between the maximum iso-
volumetric pressure and end-systolic pressure became
wider. We are the first to report these Pmax and Pes val-
ues of the RV in endotoxic shock to our knowledge.
Using these pressures, we showed that the ventricular–ar-
terial coupling ratio (VACR) – as a relatively load inde-
pendent measure of RV chamber performance –
recovered during esmolol infusion. Esmolol improving
cardiac mechanical efficiency with reduced myocardial
oxygen consumption is in agreement with other studies
(Morelli et al. 2016; Du et al. 2017). However, in our
model, the observed damped RV systolic and diastolic
function outweighs this positive effect. The reduced RV
function resulted in a declined MAP to critical values and
venous congestion during esmolol infusion. Lowering
VACR – in order to increase cardiac efficiency – is only
beneficial when adequate perfusion pressures are main-
tained. This advocates for a more subtle use of esmolol
during septic shock.
Here, the microcirculation remained compromised
while the perfusion pressure was reduced. This may possi-
bly explain why Jacquet-Lagreze et al. did demonstrate a
small improvement of some of the microcirculatory
Figure 3. Microcirculatory variables per study phase. Data are
expressed as mean  SD. Bonferroni’s post-hoc test was used to
perform pairwise comparisons between phases, *=P < 0.05.
Microcirculatory parameters: total vessel density (TVD), proportion
of perfused vessels (PPV), and perfused vessel density (PVD).
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parameters, since they had an increase in perfusion pres-
sure (Jacquet-Lagreze et al. 2015). Our poor microcircula-
tory state was highlighted by increased lactate levels,
microvascular shunting and reduced microcirculatory per-
fusion parameters. While lactate levels increased signifi-
cantly, the pCO2 gap (Pcv-aCO2) remained stable
(<6 mmHg), indicative of microvascular shunting (Haase
and Perner 2011). This is supported by the high levels of
ScvO2 (>85%).
Our data differ from several clinical studies that show
beneficial effects of esmolol in patients with septic shock
(Morelli et al. 2013a, 2013b, 2014, 2016; Guarracino et al.
2014; Du et al. 2016). These studies show increased SV,
maintained MAP and reduced nor-epinephrine require-
ments (Morelli et al. 2013a, 2014, 2016). Furthermore,
they observe an increased microcirculatory blood flow
and improved RV systolic function after esmolol infusion,
while the effect in RV diastolic function remained
unstudied (Morelli et al. 2013b; Du et al. 2016). These
discrepancies with our results could be explained by sev-
eral factors:
First, a nonlinear dose response of esmolol on MAP,
CO, and SV has been reported (Suzuki et al. 2005).
Titrating esmolol to a relative opposed to an absolute HR
reduction may have required a higher esmolol infusion
rate and therefore induce a different hemodynamic
response. Therefore, while HR reduction was the primary
target, one should never stop assessing other hemody-
namic parameters while titrating esmolol.
Second, we only studied the short-term effects of esmo-
lol. An immediate esmolol induced depression of LV ejec-
tion fraction (EF) on day 1 due to the direct negative
inotropic effect has been reported, while long-term effects
showed an increase in the EF (Hall et al. 1995). The
potent myocardial protection of esmolol by reducing
myocardial oxygen metabolism could be more relevant
beyond our studied-acute setting, since endothelial dam-
age would typically occur only after 48 h in clinical set-
ting (Hein et al. 2005). In very early septic shock,
reducing HR might counteract the compensatory tachy-
cardia due to a reduced contractility, making this therapy
strategy harmful in this condition.
Third, there is no consistency in the (simultaneous)
use of fluids and/or vasoactive agents during esmolol
therapy, making it hard to compare clinical and experi-
mental results. We kept dobutamine infusion rate con-
stant in all animals but did increase nor-adrenaline in
order to sustain the MAP. Esmolol might have blunted
the dobutamine effects, further worsening the right ven-
tricular function.
Last, while high doses of esmolol have consistently been
associated with nondeleterious effects on cardiac function
in small-animal models of sepsis (Suzuki et al. 2005; Mori
et al. 2011), the results are the opposite in some large-
animal models like ours (Aboab et al. 2011; Jacquet-
Lagreze et al. 2015). The applied LPS dose and duration
vary significantly between different animal models; hence
the induced changes and effect of esmolol also vary (Fink
2014). Our loading dose of LPS could have induced a
more pronounced cytokine response compared to a con-
tinuous infusion only.
Limitations
We used an experimental animal model with a limited
number of animals, only females, and no sham treatment.
Stopping esmolol infusion before the end of the experi-
ment allowed us not to use a sham group since the ani-
mals were their own controls. However, the effect of the
ongoing septic shock and resuscitation maneuvers should
be kept in mind. In order to monitor urine production
by urethral catheterization, we were limited to using only
female animals. Knowing that the ideal model of sepsis
does not exist, our sheep model has proven to be conve-
nient, reproducible, representative of the human condi-
tion, and met all the criteria of hyperdynamic shock
(Nemzek et al. 2008; Kiers et al. 2017).
Furthermore, the duration of the experiment was rela-
tively short [range: 7–9 h], making this experimental
design inapplicable to study organ dysfunction and out-
come. The duration of each phase could also limit the
studied changes in microcirculatory parameters. While
the blood flow in the microcirculation can fall quickly,
recruitment might have taken place if therapy was pro-
longed. To further study the effect of HR reduction on
the VACR, simultaneous recording of intraventricular
pressure and volume is advised. This would allow for
assessment of end-systolic ventricular elastance in order
to quantify the ratio between ventricular and arterial elas-
tance. However, we were unable to generate useful ultra-
sound images of the RV nor absolute end-diastolic and
end-systolic RV volumes using a conductance catheter in
our animal model (McCabe et al. 2014).
In conclusion, in this animal model of acute resusci-
tated severe endotoxic septic shock, esmolol decreased RV
function resulting in reduced perfusion pressure, venous
congestion, and unimproved microcirculation. For this
reason, clinical diligence and caution are necessary when
treating septic shock with esmolol in the acute phase.
Acknowledgments
The authors like to thank Alex Hansen for his excellent
technical assistance; M.R. Hollander from the Department
of Cardiology, VU University Medical Center, Amster-
dam, The Netherlands, for providing the Philips Volcano
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
2018 | Vol. 6 | Iss. 18 | e13882
Page 7
L. M. van Loon et al. Influence of Esmolol on Right Ventricle in Sepsis
ComboMap; M.A. van Lavieren from the AMC Heart
Center, Academic Medical Center - University of Amster-
dam, Amsterdam, The Netherlands for providing FFR-
catheters.
Conflict of Interest
None declared.
References
Aboab, J., V. Sebille, M. Jourdain, J. Mangalaboyi, M. Gharbi,
A. Mansart, et al. 2011. Effects of esmolol on systemic and
pulmonary hemodynamics and on oxygenation in pigs with
hypodynamic endotoxin shock. Intensive Care Med.
37:1344–1351.
Angus, D. C., W. T. Linde-Zwirble, J. Lidicker, G.
Clermont, J. Carcillo, and M. R. Pinsky. 2001.
Epidemiology of severe sepsis in the United States:
analysis of incidence, outcome, and associated costs of
care. Crit. Care Med. 29:1303–1310.
Cortina, C., J. Bermejo, R. Yotti, M. M. Desco, D. Rodriguez-
Perez, J. C. Antoranz, et al. 2007. Noninvasive assessment of
the right ventricular filling pressure gradient. Circulation
116:1015–1023.
Damman, K., V. M. van Deursen, G. Navis, A. A. Voors, D.
J. van Veldhuisen, and H. L. Hillege. 2009. Increased
central venous pressure is associated with impaired renal
function and mortality in a broad spectrum of patients
with cardiovascular disease. J. Am. Coll. Cardiol.
53:582–588.
De Backer, D., S. Hollenberg, C. Boerma, P. Goedhart, G.
B€uchele, G. Ospina-Tascon, et al. 2007. How to evaluate the
microcirculation: report of a round table conference. Crit.
Care 11:R101.
Dekleva, M., J. S. Lazic, I. Soldatovic, S. Inkrot, A.
Arandjelovic, F. Waagstein, et al. 2015. Improvement of
ventricular-arterial coupling in elderly patients with heart
failure after beta blocker therapy: results from the CIBIS-
ELD trial. Cardiovasc. Drugs Ther. 29:287–294.
Dickstein, M. L., O. Yano, H. M. Spotnitz, and D. Burkhoff.
1995. Assessment of right ventricular contractile state with
the conductance catheter technique in the pig. Cardiovasc.
Res. 29:820–826.
Du, W., X.-T. Wang, Y. Long, and D.-W. Liu. 2016. Efficacy
and safety of esmolol in treatment of patients with septic
shock. Chin. Med. J. (Engl) 129:1658–1665.
Du, W., D. Liu, Y. Long, and X. Wang. 2017. The b-blocker
esmolol restores the vascular waterfall phenomenon after
acute endotoxemia. Crit. Care Med. 45:e1247–e1253.
Fink, M. P. 2014. Animal models of sepsis. Virulence 5:143–
153.
Firstenberg, M. S., N. L. Greenberg, M. L. Main, J. K.
Drinko, J. A. Odabashian, J. D. Thomas, et al. 2001.
Determinants of diastolic myocardial tissue Doppler
velocities: influences of relaxation and preload. J. Appl.
Physiol. 90:299–307.
Guarracino, F., R. Baldassarri, and M. R. Pinsky. 2013.
Ventriculo-arterial decoupling in acutely altered
hemodynamic states. Crit. Care 17:213.
Guarracino, F., B. Ferro, A. Morelli, P. Bertini, R. Baldassarri,
and M. R. Pinsky. 2014. Ventriculoarterial decoupling in
human septic shock. Crit. Care 18:R80.
Haase, N., and A. Perner. 2011. Central venous oxygen
saturation in septic shock–a marker of cardiac output,
microvascular shunting and/or dysoxia? Crit. Care 15:184.
Hall, S. A., C. G. Cigarroa, L. Marcoux, R. C. Risser, P. A.
Grayburn, and E. J. Eichhorn. 1995. Time course of
improvement in left ventricular function, mass and
geometry in patients with congestive heart failure treated
with beta-adrenergic blockade. J. Am. Coll. Cardiol.
25:1154–1161.
Harkin, D. W., A. A. D’Sa, M. M. Yassin, I. S. Young, J.
McEneny, D. McMaster, et al. 2000. Reperfusion injury is
greater with delayed restoration of venous outflow in
concurrent arterial and venous limb injury. Br. J. Surg.
87:734–741.
Hein, O. V., K. Misterek, J.-P. Tessmann, V. van Dossow, M.
Krimphove, and C. Spies. 2005. Time course of endothelial
damage in septic shock: prediction of outcome. Crit. Care 9:
R323–R330.
Hernandez, G., P. Tapia, L. Alegrıa, D. Soto, C. Luengo, J.
Gomez, et al. 2016. Effects of dexmedetomidine and esmolol
on systemic hemodynamics and exogenous lactate clearance
in early experimental septic shock. Crit. Care 20:234.
Hosokawa, K., F. Su, F. S. Taccone, E. H. Post, A. J. Pereira,
A. Herpain, et al. 2017. Esmolol administration to control
tachycardia in an ovine model of peritonitis. Anesth. Analg.
125:1952–1959.
Ince, C. 2015. To beta block or not to beta block; that is the
question. Crit. Care 19:339.
Jacquet-Lagreze, M., B. Allaouchiche, D. Restagno, C. Paquet,
J.-Y. Ayoub, J. Etienne, et al. 2015. Gut and sublingual
microvascular effect of esmolol during septic shock in a
porcine model. Crit. Care 19:241.
Kanzaki, H., S. Nakatani, T. Kawada, M. Yamagishi, K.
Sunagawa, and K. Miyatake. 2002. Right ventricular dp/dt/
pmax, not dp/dtmax, noninvasively derived from tricuspid
regurgitation velocity is a useful index of right ventricular
contractility. J. Am. Soc. Echocardiogr. 15:136–142.
Kiers, D., R. M. Koch, L. Hamers, J. Gerretsen, E. J. M.
Thijs, L. van Ede, et al. 2017. Characterization of a model
of systemic inflammation in humans in vivo elicited by
continuous infusion of endotoxin. Sci. Rep. 7:40149.
Lambermont, B., P. Segers, A. Ghuysen, V. Tchana-Sato, P.
Morimont, J.-M. Dogne, et al. 2004. Comparison between
single-beat and multiple-beat methods for estimation of
right ventricular contractility. Crit. Care Med. 32:1886–1890.
2018 | Vol. 6 | Iss. 18 | e13882
Page 8
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
Influence of Esmolol on Right Ventricle in Sepsis L. M. van Loon et al.
Leeuwenburgh, B. P. J., P. Steendijk, W. A. Helbing, and J.
Baan. 2002. Indexes of diastolic RV function: load
dependence and changes after chronic RV pressure overload
in lambs. Am. J. Physiol. Heart Circ. Physiol. 282:H1350–
H1358.
Legrand, M., C. Dupuis, C. Simon, E. Gayat, J. Mateo, A.-C.
Lukaszewicz, et al. 2013. Association between systemic
hemodynamics and septic acute kidney injury in critically ill
patients: a retrospective observational study. Crit. Care 17:R278.
Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003.
The epidemiology of sepsis in the United States from 1979
through 2000. N. Engl. J. Med. 348:1546–1554.
Mayr, F. B., S. Yende, and D. C. Angus. 2014. Epidemiology of
severe sepsis. Virulence 5:4–11.
McCabe, C., P. A. White, S. P. Hoole, R. G. Axell, A. N.
Priest, D. Gopalan, et al. 2014. Right ventricular dysfunction
in chronic thromboembolic obstruction of the pulmonary
artery: a pressure-volume study using the conductance
catheter. J. Appl. Physiol. 116:355–363.
Morelli, A., C. Ertmer, M. Westphal, S. Rehberg, T.
Kampmeier, S. Ligges, et al. 2013a. Effect of heart rate
control with esmolol on hemodynamic and clinical
outcomes in patients with septic shock: a randomized
clinical trial. JAMA 310:1683–1691.
Morelli, A., A. Donati, C. Ertmer, S. Rehberg, T. Kampmeier,
A. Orecchioni, et al. 2013b. Microvascular effects of heart
rate control with esmolol in patients with septic shock: a
pilot study. Crit. Care Med. 41:2162–2168.
Morelli, A., A. D’Egidio, A. Orecchioni, E. Maraffa, and S.
Romano. 2014. Heart rate reduction with esmolol in septic
shock: effects on myocardial performance. Crit. Care 18:
P162.
Morelli, A., M. Singer, V. M. Ranieri, A. D’Egidio, L. Mascia,
A. Orecchioni, et al. 2016. Heart rate reduction with
esmolol is associated with improved arterial elastance in
patients with septic shock: a prospective observational study.
Intensive Care Med. 42:1528–1534.
Mori, K., H. Morisaki, S. Yajima, T. Suzuki, A. Ishikawa, N.
Nakamura, et al. 2011. Beta-1 blocker improves survival of
septic rats through preservation of gut barrier function.
Intensive Care Med. 37:1849–1856.
Nemzek, J. A., K. M. S. Hugunin, and M. R. Opp. 2008.
Modeling sepsis in the laboratory: merging sound science
with animal well-being. Comp. Med. 58:120–128.
Orbegozo Cortes, D., H. Njimi, A. M. Dell’Anna, and F. S.
Taccone. 2014. Esmolol for septic shock: more than just
heart rate control? Minerva Anestesiol. 80:254–258.
Park, Y., R. Hirose, K. Dang, F. Xu, M. Behrends, V. Tan,
et al. 2008. Increased severity of renal ischemia-reperfusion
injury with venous clamping compared to arterial clamping
in a rat model. Surgery 143:243–251.
Pinsky, M. R. 2013. Is there a role for b-blockade in septic
shock? JAMA 310:1677–1678.
Razzolini, R., G. Tarantini, G. M. Boffa, S. Orlando, and S.
Iliceto. 2004. Effects of carvedilol on ventriculo-arterial
coupling in patients with heart failure. Ital. Heart. J. 5:517–
522.
Sun, Y., I. Belenkie, J.-J. Wang, and J. V. Tyberg. 2006.
Assessment of right ventricular diastolic suction in dogs
with the use of wave intensity analysis. Am. J. Physiol. Heart
Circ. Physiol. 291:H3114–H3121.
Sunagawa, K., A. Yamada, Y. Senda, Y. Kikuchi, M.
Nakamura, T. Shibahara, et al. 1980. Estimation of the
hydromotive source pressure from ejecting beats of the left
ventricle. IEEE Trans. Biomed. Eng. BME–27:299–305.
Suzuki, T., H. Morisaki, R. Serita, M. Yamamoto, Y. Kotake,
A. Ishizaka, et al. 2005. Infusion of the beta-adrenergic
blocker esmolol attenuates myocardial dysfunction in septic
rats. Crit. Care Med. 33:2294–2301.
Takeuchi, M., Y. Igarashi, S. Tomimoto, M. Odake, T.
Hayashi, T. Tsukamoto, et al. 1991. Single-beat estimation
of the slope of the end-systolic pressure-volume relation in
the human left ventricle. Circulation 83:202–212.
Truong, U., S. Patel, V. Kheyfets, J. Dunning, B. Fonseca, A. J.
Barker, et al. 2015. Non-invasive determination by
cardiovascular magnetic resonance of right ventricular-
vascular coupling in children and adolescents with
pulmonary hypertension. J. Cardiovasc. Magn. Reson. 17:81.
Weiss, J. L., J. W. Frederiksen, and M. L. Weisfeldt. 1976.
Hemodynamic determinants of the time-course of fall in
canine left ventricular pressure. J. Clin. Invest. 58:751–
760.
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
2018 | Vol. 6 | Iss. 18 | e13882
Page 9
L. M. van Loon et al. Influence of Esmolol on Right Ventricle in Sepsis
